PAG
CRMD icon

Private Advisor Group’s CorMedix CRMD Stock Holding History

Private Advisor Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Sell
415,406
-89,262
-18% -$705K 0.01% 806
2026
Q1 		$3.43M Buy
504,668
+126,131
+33% +$932K 0.02% 798
2025
Q4 		$4.4M Buy
378,537
+105,452
+39% +$1.17M 0.02% 675
2025
Q3 		$3.18M Buy
273,085
+193,075
+241% +$2.33M 0.02% 811
2025
Q2 		$986K Sell
80,010
-5,499
-6% -$60.7K 0.01% 1317
2025
Q1 		$527K Buy
85,509
+69,285
+427% +$717K ﹤0.01% 1573
2024
Q4 		$131K Sell
16,224
-5,436
-25% -$54.3K ﹤0.01% 2152
2024
Q3 		$175K Sell
21,660
-9,800
-31% -$53K ﹤0.01% 2248
2024
Q2 		$136K Hold
31,460
– – ﹤0.01% 2198
2024
Q1 		$133K Hold
31,460
– – ﹤0.01% 2167
2023
Q4 		$118K Sell
31,460
-340
-1% -$1.17K ﹤0.01% 2101
2023
Q3 		$118K Sell
31,800
-6,110
-16% -$24.3K ﹤0.01% 1951
2023
Q2 		$150K Hold
37,910
– – ﹤0.01% 1887
2023
Q1 		$157K Hold
37,910
– – ﹤0.01% 1823
2022
Q4 		$160 Buy
37,910
+200
+0.5% +$708 ﹤0.01% 1540
2022
Q3 		$107K Buy
37,710
+17,000
+82% +$70.7K ﹤0.01% 1773
2022
Q2 		$83K Sell
20,710
-1,269
-6% -$4.71K ﹤0.01% 1970
2022
Q1 		$120K Buy
21,979
+1,900
+9% +$8.7K ﹤0.01% 1975
2021
Q4 		$91K Buy
20,079
+1,700
+9% +$8.44K ﹤0.01% 2034
2021
Q3 		$85K Sell
18,379
-2,500
-12% -$14.6K ﹤0.01% 1958
2021
Q2 		$143K Hold
20,879
– – ﹤0.01% 1871
2021
Q1 		$209K Sell
20,879
-1,110
-5% -$11.7K ﹤0.01% 1715
2020
Q4 		$163K Sell
21,989
-200
-0.9% -$1.36K ﹤0.01% 1653
2020
Q3 		$134K Sell
22,189
-4,000
-15% -$20.1K ﹤0.01% 1464
2020
Q2 		$165K Buy
26,189
+2,520
+11% +$11.7K ﹤0.01% 1446
2020
Q1 		$85K Hold
23,669
– – ﹤0.01% 1338
2019
Q4 		$172K Buy
23,669
+2,642
+13% +$16.1K ﹤0.01% 1513
2019
Q3 		$134K Sell
21,027
-2,600
-11% -$21.8K ﹤0.01% 1559
2019
Q2 		$212K Buy
23,627
+6,800
+40% +$53.4K ﹤0.01% 1480
2019
Q1 		$159K Buy
16,827
+2,220
+15% +$20K ﹤0.01% 1450
2018
Q4 		$94K Buy
14,607
+259
+2% +$1.73K ﹤0.01% 1298
2018
Q3 		$69K Buy
14,348
+11,900
+486% +$29.3K ﹤0.01% 1556
2018
Q2 		$3K Sell
2,448
-9,352
-79% -$10.8K ﹤0.01% 1300
2018
Q1 		$11K Buy
11,800
+9,052
+329% +$18.1K ﹤0.01% 1146
2017
Q4 		$8K Sell
2,748
-12,067
-81% -$34.6K ﹤0.01% 1179
2017
Q3 		$46K Hold
14,815
– – ﹤0.01% 1437
2017
Q2 		$30K Sell
14,815
-2,918
-16% -$9.98K ﹤0.01% 1365
2017
Q1 		$134K Sell
17,733
-1,952
-10% -$18.6K ﹤0.01% 1334
2016
Q4 		$173K Sell
19,685
-5,682
-22% -$57.5K 0.01% 1178
2016
Q3 		$356K Buy
25,367
+3,700
+17% +$34.6K 0.01% 771
2016
Q2 		$195K Buy
21,667
+2,700
+14% +$41.1K 0.01% 1001
2016
Q1 		$251K Buy
18,967
+8,160
+76% +$79.2K 0.01% 825
2015
Q4 		$110K Buy
+10,807
New +$124K 0.01% 1016

Other funds holding CRMD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
WWA
Wingate Wealth Advisors Lexington, Massachusetts $227M AUM 18.87% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
AFA
American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
WMA
West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Private Advisor Group's CRMD Position: Q2 2026 in Review

Private Advisor Group reduced its CorMedix (CRMD) stake by 18% in Q2 2026, selling an estimated $705K and leaving 415,406 shares worth $3.26M. The position accounts for 0.01% of the portfolio, ranked #806.

Private Advisor Group first reported a position in CRMD in Q4 2015 and has held it in 43 quarters since. The position peaked at $4.4M in Q4 2025. 34 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Private Advisor Group held 415,406 shares of CorMedix worth $3.26M as of Q2 2026.
  • Private Advisor Group sold 89,262 CorMedix shares in Q2 2026, an estimated $705K.
  • CorMedix made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #806 holding.
  • Private Advisor Group first reported a position in CorMedix in Q4 2015 and has held it in 43 quarters since.
  • Private Advisor Group's CorMedix position peaked at $4.4M in Q4 2025.
  • 34 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.